Back to CAPSTONE INVESTMENT ADVISORS, LLC CAPSTONE INVESTMENT ADVISORS, LLC

EWEW

Showing 8 of 28 quarters

Position history for CAPSTONE INVESTMENT ADVISORS, LLCCAPSTONE INVESTMENT ADVISORS, LLC's holdings in EDWARDS LIFESCIENCES CORP

No. Capstone Investment Advisors exited its EW (Edwards Lifesciences) position in Q2 2026. Its Q1 2026 13F listed 4,024 shares worth $322,242. Capstone Investment Advisors already held EW in its Q4 2018 13F, the earliest on record, and held it in 24 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$1.6M

Total Shares Change

-24,789

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$90.46
0
2026-Q1
Decreased
4,024
-45.0%
$322,2420.0%$80.08
0
2025-Q4
Decreased
7,318
-46.3%
$623,8600.0%$85.25
0
2025-Q3
Decreased
13,632
-34.1%
$1.1M0.0%$77.77
0
2025-Q2
Increased
20,700
+72.8%
$1.6M0.0%$78.21
38
2025-Q1
Decreased
11,977
-40.7%
$868,0930.0%$72.48
0
2024-Q4
Decreased
20,194
-18.5%
$1.5M0.0%$74.03
0
2024-Q3
Increased
24,789
+734.4%
$1.6M0.0%$65.99
41

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used